MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug metformin tested to halt blood cancer before it starts
Prevention OngoingThis study tests whether metformin, a widely used diabetes medicine, can prevent two pre-cancer conditions (MGUS and smoldering myeloma) from turning into active multiple myeloma. About 60 adults with higher-risk MGUS or low-risk smoldering myeloma will receive either metformin o…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 16, 2026 12:48 UTC
-
Plant-Based diet trial aims to stop precancerous blood condition from turning into multiple myeloma
Prevention OngoingThis study tests whether a plant-based diet is practical for overweight people with MGUS or smoldering multiple myeloma, two conditions that can lead to multiple myeloma. Researchers will measure weight loss and how well participants stick to the diet over 12 weeks. They will als…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC
-
Iceland launches massive screening study to detect cancer risk before it strikes
Knowledge-focused OngoingThis study looks at whether screening for MGUS, a condition that can lead to multiple myeloma, helps people live longer. Over 80,000 adults in Iceland born in 1975 or earlier were invited to participate. The goal is to see if early detection and follow-up can improve survival and…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: University of Iceland • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
1000 adults screened for blood condition that can lead to cancer
Knowledge-focused ENROLLING_BY_INVITATIONThis study screens 1000 adults aged 40 and older for MGUS, a condition with an abnormal blood protein that sometimes turns into multiple myeloma. Researchers aim to learn about genetic and immune factors across diverse groups in Minnesota. The goal is to improve early detection a…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC